Variation of marketing authorisation, registration, exemption

Legal basis

REGULATION (EU) 2019/6 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC shall apply from 28 January 2022.

Gesetz zum Erlass eines Tierarzneimittelgesetzes und zur Anpassung arzneimittelrechtlicher und anderer Vorschriften vom 27. September 2021 (TAMG)

Handling of Changes

Changes to the terms of the marketing authorisations or registration or changes to the information accompanying the application for exemption shall be notified to the BVL in accordance with the relevant legal basis.

Changes to the terms of the marketing authorisations are also referred to as variations.  

Regulation (EU) 2019/6 rules

Variations to the terms of a marketing authorisation that do not require an assessment - commonly also referred to as variations not requiring assessment (VNRA) and

Variations to marketing authorisation conditions that require an assessment - commonly referred to as Variations requiring assessment (VRA).

§ 4 (4) TAMG applies to changes to the informaton accompanying the application for exemption.

Further guidance on variations is available on the following websites:

The website of the coordination group (CMDv) includes information on not already listed variations.

Further information on the procedures can be found here.

Notes on administrative practice

Submission via CESP is mandatory for submissions in MRP/DCP and is also strongly recommended for National Procedures (NP).Eudralink or email is accepted for formal submissions in purely NP.

Contact email for national variations:

tam-aenderungsanzeigen@bvl.bund.de

Contact email for variations in MR/DC procedures:

variations@bvl.bund.de

Contact email for enquiries towards exempted TAMs:

tam-freistellung@bvl.bund.de

Requests for supplementary information will be sent to the email address of the contact person stated in the electronic application form. The corresponding email triggers the deadline for the amendment of deficiencies.

Fees

The BVL reserves the right to charge fees and expenses for the processing of variations for purely national marketing authorisations.